Morphogenesis, Inc. Moves Forward With Development of Cancer Vaccine

UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, has been working on the research for nearly 20 years and has already completed phase one of its clinical trial on the treatment which the company says will be directly inserted into cancerous tumors through several methods. 

“It actually triggers the early response and immune response to cancer and allows the immune response to develop,” said Michael Lawman, president of Morphogenesis.  

Learn more about Morphogenesis, Inc. Moves Forward With Development of Cancer Vaccine.